Q/C TECHNOLOGIES, INC. — Director's Dealing 2018

Apr 11, 2018

SEC Form 4/A — Form 4/A

Issuer: Akers Biosciences, Inc. (AKER)
CIK: 0001321834
Period of Report: 2016-06-08

Reporting Person: Gormally John J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-08	Common Stock	A	27500	$1.99	Acquired	30000	Direct

Footnotes

F1: On June 8, 2016 Mr. Gormally was issued 27,500 shares of common stock (the "Shares") under the Company's 2013 Incentive Stock and Award Plan, as amended. Pursuant to the Restricted Stock Agreement between Mr. Gormally and the Company governing the issuance of the Shares, 9,167 of the Shares vested on June 8, 2016, 9,167 of the Shares will vest on March 1, 2017, and 9,166 of the Shares will vest on March 1, 2018.